Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer.

American journal of clinical oncology

Volumn 26, Issue 5, 2003, Pages

  Youssef, Emad ^a   Tekyi Mensah, Samuel ^a   Hart, Kimberly ^a   Bolton, Susan ^a   Forman, Jeffrey ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GONADORELIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; DISEASE COURSE; DRUG POTENTIATION; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PATHOLOGY; PROSTATE TUMOR; QUALITY OF LIFE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE PROGRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 1542673411     PISSN: None     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000091351.09243.15     Document Type: Article

References (0)